|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified recombinant fragment of human ENO2 (amino acids: 251-433) expressed in E. Coli.|
|Storage buffer||PBS with 0.5% proprietary stabilizer|
|Contains||0.05% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||1:200 - 1:400|
|Immunohistochemistry (IHC)||1:200 - 1:1000|
|Western Blot (WB)||1:500 - 1:2000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 1 publications below|
MA5-17072 targets ENO2 in FACS, IHC, pep-ELISA, and WB applications and shows reactivity with Human and Mouse samples.
The MA5-17072 immunogen is purified recombinant fragment of human ENO2 (amino acids: 251-433) expressed in E. Coli.
MA5-17072 detects ENO2 which has a predicted molecular weight of approximately 47.3kDa.
This gene encodes one of the three enolase isoenzymes found in mammals. This isoenzyme, a homodimer, is found in mature neurons and cells of neuronal origin. A switch from alpha enolase to gamma enolase occurs in neural tissue during development in rats and primates.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.
MA5-17072 was used in immunohistochemistry and western blot to study the molecular mechanisms underlying the therapeutic effects of propionyl-L-carnitine in a rat model of ulcerative colitis
|Scioli MG,Stasi MA,Passeri D,Doldo E,Costanza G,Camerini R,Fociani P,Arcuri G,Lombardo K,Pace S,Borsini F,Orlandi A||Clinical and translational gastroenterology (5:null)||2014|